cognitive cybersecurity intelligence

News and Analysis

Search

Worldwide Clinical Trials to Buy Catalyst, Another M&A Deal Between Private Equity-Backed CROs

Worldwide Clinical Trials to Buy Catalyst, Another M&A Deal Between Private Equity-Backed CROs

The contract research organization consolidation trend continues with Worldwide Clinical Trials striking a deal for Catalyst Clinical Research, which has particular expertise in oncology. Worldwide is a portfolio company of Kohlberg, a private equity firm.
The post Worldwide Clinical Trials to Buy Catalyst, Another M&A Deal Between Private Equity-Backed CROs appeared first on MedCity News.

Source: medcitynews.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts

What is User Managed Access?

What is User Managed Access?

Deep dive into User Managed Access (UMA). Learn how UMA 2.0 works with OAuth2 and OIDC to provide user-centric privacy and resource sharing in Enterprise